Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice

Behavioural Brain Research

Volumn 235, Issue 1, 2012, Pages 1-6

  Chen, Shuang Qing ^a   Cai, Qing ^a   Shen, Yu Ying ^a   Wang, Pei Jun ^b   Teng, Gao Jun ^c   Zhang, Wei ^b   Zang, Feng Chao ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c SOUTHEAST UNIVERSITY   (China)

Author keywords

Alzheimer's disease (AD); Magnetic resonance spectroscopy (MRS); Metabolite; Morris water maze (MWM)

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CHOLINE; CREATINE; GLUTAMIC ACID; INOSITOL; N ACETYLASPARTIC ACID; PRESENILIN 1;

AGE DISTRIBUTION; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; COGNITION; CONTROLLED STUDY; HIPPOCAMPUS; LEARNING; MAZE TEST; MEMORY; MORRIS WATER MAZE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSGENIC MOUSE; WILD TYPE;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASPARTIC ACID; BIOLOGICAL MARKERS; CHOLINE; CREATINE; DISEASE MODELS, ANIMAL; FUNCTIONAL NEUROIMAGING; GLUTAMIC ACID; HIPPOCAMPUS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MAZE LEARNING; MICE; MICE, TRANSGENIC; PRESENILIN-1; PROTONS;

EID: 84864565343     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.07.016     Document Type: Article

References (48)

1. Delacourte A., David J.P., Sergeant N., Buee L., Wattez A., Vermersch P., et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999, 52:1158-1165.
2. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Archives of Neurology 2003, 60:1119-1122.
3. Griffith V.T. Diagnose and treat mild to moderate Alzheimer's disease. Nurse Practitioner 2003, 27:13-25.
4. Terry A.V., Callahan P.M., Hall B., Webster S.J. Alzheimer's disease and age-related memory decline (preclinical). Pharmacology Biochemistry and Behavior 2011, 99:190-210.
5. Montgomerya K.S., Simmonsa R.K., Edwards G., Nicolle M.M., Gluck M.A., Myers C.E., et al. Novel age-dependent learning deficits in a mouse model of Alzheimer's disease: implications for translational research. Neurobiology of Aging 2011, 32:1273-1285.
6. Lalonde R., Kim H.D., Maxwell J.A., Fukuchi K. Exploratory activity and spatial learning in 12-month-old APP695SWE/co+PS1/Delta E9 mice with amyloid plaques. Neuroscience Letters 2005, 390:87-92.
7. Gordon M.N., King D.L., Diamond D.M., Jantzen P.T., Boyett K.V., Hope C.E., et al. Correlation between cognitive deficits and Aβ deposits in transgenic APP1PS1 mice. Neurobiology of Aging 2001, 22:377-386.
8. Pugh P.L., Richardson J.C., Bate S.T., Upton N., Sunter D. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease. Behavioural Brain Research 2007, 178:18-28.
9. Liu L., Ikonen S., Heikkinen T., Heikkilä M., Puoliväli J., van Groen T., et al. Effects of fimbria-fornix lesion and amyloid pathology on spatial learning and memory in transgenic APP/PS1 mice. Behavioural Brain Research 2002, 134:433-445.
10. Gulinello M., Gertner M., Mendoza G., Schoenfeld B.P., Oddod S., LaFerla F., et al. Validation of a 2-day water maze protocol in mice. Behavioural Brain Research 2009, 196:220-227.
11. Ewers M., Morgan D.G., Gordon M.N., Woodruff-Pak D.S. Associative and motor learning in 12-month-old transgenic APP+PS1 mice. Neurobiology of Aging 2006, 27:1118-1128.
12. Wirths O., Breyhan H., Schafer S., Roth C., Bayer T.A. Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease. Neurobiology of Aging 2008, 29:891-901.
13. Filalia M., Lalonde R. Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease. Brain Research 2009, 1292:93-99.
14. Prut L., Abramowski D., Krucker T., Levy C.L., Roberts A.J., Staufenbiel M., et al. Aged APP23 mice show a delay in switching to the use of a strategy in the Barnes maze. Behavioural Brain Research 2007, 179:107-110.
15. Bianchi S.L., Tran T., Liu C.L., Lin S.S., Li Y.J., Keller J.M., et al. Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics. Neurobiology of Aging 2008, 29:1002-1010.
16. D'Hooge R., De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Research. Brain Research Reviews 2001, 36:60-90.
17. Kelly P.H., Bondolfi L., Hunziker D., Schlecht H.P., Carver K., Maguire E., et al. Progressive age-related impairment of cognitive behavior in APP23 transgenic mice. Neurobiology of Aging 2003, 24:365-378.
18. Metastasio A., Rinaldi P., Tarducci R., Mariani E., Feliziani F.T., Cherubini A., et al. Conversion of MCI to dementia: role of proton magnetic resonance spectroscopy. Neurobiology of Aging 2006, 27:926-932.
19. Woo D.C., Lee S.H., Lee D.W., Kim S.Y., Kim G.Y., Rhim H.S., et al. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS. Behavioural Brain Research 2010, 211:125-131.
20. Yang D., Xie Z.Y., Stephenson D., Morton D., Hicks C.D., Brown T.M., et al. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510). NeuroImage 2011, 54:2652-2658.
21. Salek R.M., Xia J., Innes A., Sweatman B.C., Adalbert R., Randle S., et al. A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. Neurochemistry International 2010, 56:937-947.
22. Michaelis T., Boretius S., Frahm J. Localized proton MRS of animal brain in vivo: models of human disorders. Progress in Nuclear Magnetic Resonance Spectroscopy 2009, 55:1-34.
23. Ross B.D., Bluml S., Cowan R., Danielsen E., Farrow N., Tan J. In vivo MR spectroscopy of human dementia. Neuroimaging Clinics of North America 1998, 8:809-822.
24. Gruart A., López-Ramos J.C., Muñoz M.D., Delgado-Garcíaa J.M. Aged wild-type and APP PS1, and APP+PS1 mice present similar deficits in associative learning and synaptic plasticity independent of amyloid load. Neurobiology of Disease 2008, 30:439-450.
25. Xu W., Zhan Y.Q., Huang W., Wang X.X., Zhang S.M., Lei H. Reduction of hippocampal N-acetyl aspartate level in aged APPSwe/PS1dE9 transgenic mice is associated with degeneration of CA3 pyramidal neurons. Journal of Neuroscience Research 2010, 88:3155-3160.
26. Codita A., Winblad B., Mohammed A.H. Of mice and men: more neurobiology in dementia. Current Opinion in Psychiatry 2006, 19:555-563.
27. Games D., Buttini M., Kobayashi D., Schenk D., Seubert P. Mice as models: transgenic approaches and Alzheimer's disease. Journal of Alzheimer's Disease 2006, 9:133-149.
28. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., et al. Tripletransgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
29. Jankowsky J.L., Fadale D.L., Anderson J., Xu G.M., Gonzales V., Jenkins N.A., et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Human Molecular Genetics 2004, 13:159-170.
30. van Groen T., Kiliaan A.J., Kadish I. Deposition of mouse amyloid β inhuman APP/PS1 double and single AD model transgenic mice. Neurobiology of Disease 2006, 23:653-662.
31. Chen S.Q., Wang P.J., Teng G.J., Zhan W., Li M.H., Zang F.C. Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice. Dementia and Geriatric Cognitive Disorders 2009, 28:558-566.
32. Zhuoa J.M., Prescott S.L., Murray M.E., Zhang H.Y., Baxter M.G., Nicolle M.M. Early discrimination reversal learning impairment and preserved spatial learning in a longitudinal study of Tg2576 APPsw mice. Neurobiology of Aging 2007, 28:1248-1257.
33. Huang H.J., Liang K.C., Hsing-Chieh K., Chang Y.Y., Hsieh-Li H.M. Long-term social isolation exacerbates the impairment of spatial working memory in APP/PS1 transgenic mice. Brain Research 2011, 1371:150-160.
34. Jensen M.T., Mottin M.D., Cracchiolo J.R., Leighty R.E., Arendash G.W. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging. Neuroscience 2005, 130:667-684.
35. Arendash G.W., King D.L., Gordon M.N. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Research 2001, 891:42-53.
36. Ross A.J., Sachdev P.S. Magnetic resonance spectroscopy in cognitive research. Brain Research. Brain Research Reviews 2004, 44:83-102.
37. Dedeoglu A., Choi J.K., Cormier K., Kowall N.W., Jenkins B.G. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile. Brain Research 2004, 1012:60-65.
38. von Kienlin M., Künnecke B., Metzger F., Steiner G., Richards J.G., Ozmen L., et al. Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. Neurobiology of Disease 2005, 18:32-39.
39. 1H-MRS in APP/PS1 mice. Neurobiology of Aging 2008, 29:1423-1433.
40. 1H-MRS studies in vivo. Neuroreport 1996, 7:1397-1400.
41. den Heijer T., Sijens P.E., Prins N.D., Hofman A., Koudstaal P.J., Oudkerk M., et al. MR spectroscopy of brain white matter in the prediction of dementia. Neurology 2006, 66:540-544.
42. Jessen F., Traeber F., Freymann N., Maier W., Schild H.H., Heun R., et al. Comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2005, 20:178-183.
43. Hugon J., Vallat J.M., Dumas M. Role of glutamate and excitotoxicity in neurologic diseases. Revista de Neurologia 1996, 152:239-248.
44. Marjanska M., Curran G.L., Wengenack T.M., Henry P.G., Bliss R.L., Poduslo J.F., et al. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:11906-11910.
45. Firbank M.J., Harrison R.M., O'Brien J.T. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. Dementia and Geriatric Cognitive Disorders 2002, 14:64-76.
46. 1H-MRS in vitro. NMR in Biomedicine 2012, 25:52-58.
47. Kimura N., Takahashi M., Tashiro T., Terao K. Amyloid beta up-regulates brain-derived neurotrophic factor production from astrocytes: rescue from amyloid beta-related neuritic degeneration. Journal of Neuroscience Research 2006, 84:782-789.
48. Valenzuela M.J., Sachdev P. Magnetic resonance spectroscopy in AD. Neurology 2001, 56:592-598.